(Q46150411)

English

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder

scientific article published on 22 January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19165529

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19165529

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

attention deficit hyperactivity disorder

1 reference

based on heuristic

inferred from title

author name string

Michael Rösler

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19165529

Roland Fischer

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19165529

Richard Ammer

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19165529

Claudia Ose

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19165529

Wolfgang Retz

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19165529

publication date

22 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19165529

European Archives of Psychiatry and Clinical Neuroscience

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19165529

259

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19165529

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19165529

120-129

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19165529

https://scigraph.springernature.com/pub.10.1007/s00406-008-0845-4

0 references

Methylphenidate effects on symptoms of attention deficit disorder in adults.

1 reference

https://api.crossref.org/works/10.1007%2FS00406-008-0845-4

21 January 2018

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1007%2FS00406-008-0845-4

21 January 2018

A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults

1 reference

https://api.crossref.org/works/10.1007%2FS00406-008-0845-4

21 January 2018

Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report

1 reference

https://api.crossref.org/works/10.1007%2FS00406-008-0845-4

21 January 2018

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19165529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional outcomes in the treatment of adults with ADHD.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19165529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attention deficit disorders in adults.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19165529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Reliability and validity of the Wender-Utah-Rating-Scale short form. Retrospective assessment of symptoms for attention deficit/hyperactivity disorder]

1 reference

https://pubmed.ncbi.nlm.nih.gov/19165529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19165529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19165529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19165529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled, crossover study of osmotic release oral system methylphenidate in adults with ADHD with assessment of oppositional and emotional dimensions of the disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19165529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Efficacy of 2 Different Dosages of Methylphenidate in Treating Adults with Attention-Deficit Hyperactivity Disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19165529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline

1 reference

https://pubmed.ncbi.nlm.nih.gov/19165529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19165529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Attention deficit hyperactivity disorder in adults. Benchmarking diagnosis using the Wender-Reimherr adult rating scale]

1 reference

https://pubmed.ncbi.nlm.nih.gov/19165529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19165529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19165529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD).

1 reference

https://pubmed.ncbi.nlm.nih.gov/19165529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19165529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ADHD in adulthood--guidelines based on expert consensus with DGPPN support

1 reference

https://pubmed.ncbi.nlm.nih.gov/19165529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Tools for the diagnosis of attention-deficit/hyperactivity disorder in adults. Self-rating behaviour questionnaire and diagnostic checklist]

1 reference

https://pubmed.ncbi.nlm.nih.gov/19165529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology

1 reference

https://pubmed.ncbi.nlm.nih.gov/19165529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19165529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Wender Utah rating scale. The short-version for the assessment of the attention-deficit hyperactivity disorder in adults]

1 reference

https://pubmed.ncbi.nlm.nih.gov/19165529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emotional dysregulation in adult ADHD and response to atomoxetine.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19165529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment and management of attention-deficit hyperactivity disorder in adults.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19165529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/19165529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00406-008-0845-4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19165529

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19165529

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46150411&oldid=2187982282"